Pfizer, BioNTech collaborate to develop vaccine for COVID-19

This article was originally published here

Under material transfer and collaboration agreement, the companies will co-develop and supply potential mRNA-based coronavirus vaccine for the prevention of COVID-19 infection. The vaccine will not be supplied

The post Pfizer, BioNTech collaborate to develop vaccine for COVID-19 appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply